On Monday the U.S. Food and Drug Administration (FDA) has approved the hyaluronic acid (HA) dermal filler Restylane Lyft for the correction of age-related volume loss in the back of the hands for patients over the age of 21. Restylane Lyft, a product from Nestlé Skin Health, is the first and only HA injectable gel to be FDA-approved for restoring fullness to the back of the hands and is also the first-ever HA dermal filler to receive FDA approval for an area other than the face. As Undercover Agents may recall, RADIESSE, whose principle component is synthetic calcium hydroxylapatite, was approved for a similar use by the FDA in 2015.
“As we age, we lose volume in the back of the hands, causing the appearance of tendons, wrinkles and veins to become more pronounced,” stated Dr. Ellen Marmur, a board-certified dermatologist in New York City and clinical trial investigator for Restylane Lyft in the hands. “Many of my patients start to notice their youthful-looking faces aren’t matching their aging hands, and ask me what they can do about it. I am now pleased to be able to offer them Restylane Lyft, an injectable HA treatment that many are familiar with since it has been on the market for over 10 years for facial wrinkles.” (more…)